Treatment of metachronous and simultaneous liver metastases of pancreatic cancer

European Surgical Research

Volumn 44, Issue 3-4, 2010, Pages 209-213

  Dunschede F ^a   Will, L ^a   Von Langsdorf, C ^a   Mohler M ^a   Galle, P R ^a   Otto, G ^a   Vahl, C F ^a   Junginger, T ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Liver metastases, metachronous; Liver metastases, simultaneous; Pancreatic cancer

Indexed keywords

GEMCITABINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER RESECTION; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS SURGERY; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77953666565     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313532     Document Type: Article

References (13)

1. Sener SF, Fremgen A, Menck HR, Winchester DP: Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1195, using the National Cancer Database. J Am Coll Surg 1999; 189: 1-7.
2. Guojónsson B: Cancer of pancreas: 50 years of surgery. Cancer 1987; 60: 2284-2303.
3. Shrikhande SV, Kleef J, Reiser C, et al: Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 2007; 14: 118-127.
4. Klempnauer J, Ridder GJ, Piso P, Pichlmayr R: Ist die Leberresektion bei Metastasen eines exokrinen Pankreascarcinoms gerechtfertigt? Chirurg 1996; 67: 366-370.
5. Weitz J, Blumgart LH, Fong Y, et al: Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 2005; 241: 269-276.
6. Gleisner AL, Assumpcao L, Cameron JL, et al: Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? Cancer 2007; 110: 2484-2492.
7. Takada T, Yasuda H, Amano H, et al: Simultaneous hepatic resection with pancreatoduodenectomy for metastatic pancreatic head cancer: does it improve survival? Hepatogastroenterology 1997; 44: 567-573.
8. Goulart BH, Clark JW, Lauwers GY, et al: Long-term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis. J Hematol Oncol 2009; 2: 13-23.
9. Oettle H, Post S, Neuhaus P, et al: Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curativeintent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007; 297: 267-277.
10. Yamada H, Hirano S, Tanaka E, et al: Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford) 2006; 8: 85-88.
11. Heinrich S, Schäfer M, Weber A, et al: Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial. Ann Surg 2008; 248: 1014-1022.
12. Adam R, Chiche L, Aloia T, et al: Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 2006; 244: 524-535.
13. Kleeff J, Reiser C, Hinz U, et al: Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 2007; 245: 566-572. (Pubitemid 46555660)